COMBINATIONS OF TIOTROPIUM BROMIDE, FORMOTEROL AND BUDESONIDE FOR THE TREATMENT OF COPD

摘要

This invention provides a combination product comprising an inhalable long-acting muscarinic antagonist (LAMA) composition for use in the long-term treatment of COPD combined with an inhalable fixed-dose composition comprising budesonide and formoterol or a pharmaceutically acceptable salt thereof for administration pro re nata (prn) as a rescue medication for the treatment of acute exacerbations of COPD.